Clearside Biomedical's Series B Round

Clearside Biomedical raised a round of funding on September 02, 2014.

Clearside Biomedical, headquartered in Alpharetta, GA, is a clinical-stage biopharmaceutical company developing innovative first-in-class drug therapies to treat blinding diseases of the eye using Cle…

Articles about Clearside Biomedical's Series B Round: